0001376474-25-000506.txt : 20250603 0001376474-25-000506.hdr.sgml : 20250603 20250603121919 ACCESSION NUMBER: 0001376474-25-000506 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250603 DATE AS OF CHANGE: 20250603 EFFECTIVENESS DATE: 20250603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Porosome Therapeutics, Inc. CENTRAL INDEX KEY: 0001934919 ORGANIZATION NAME: EIN: 873482047 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-492097 FILM NUMBER: 251017926 BUSINESS ADDRESS: STREET 1: ONE BOSTON PLACE, STE 2631 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 781 956 9799 MAIL ADDRESS: STREET 1: ONE BOSTON PLACE, STE 2631 CITY: BOSTON STATE: MA ZIP: 02108 FORMER COMPANY: FORMER CONFORMED NAME: Viron Therapeutics Holdings, Inc. DATE OF NAME CHANGE: 20220622 D/A 1 primary_doc.xml X0708 D/A LIVE 0001934919 Porosome Therapeutics, Inc. ONE BOSTON PLACE, STE 2631 BOSTON MA MASSACHUSETTS 02108 214-394-4549 DELAWARE Viron Therapeutics Holdings, Inc. Corporation true 2021 Guillermo Marmol One Boston Place Suite 2631 Boston MA MASSACHUSETTS 02108 Executive Officer Biotechnology No Revenues 06b true 0001376474-23-000433 2023-09-08 false true false 50000 Indefinite 2500000 Indefinite false 3 0 0 0 The Chief Executive Officer, Guillermo Marmol, receives no compensation from the proceeds. false Porosome Therapeutics, Inc. /s/ Guillermo Marmol Guillermo Marmol Chief Executive Officer 2025-06-02